PA

sponsor

Your Unread Messages

Hello, Mary O'connor
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hu YB et al. – SP600125 has the potential to remarkably attenuate steatosis and inflammation and may be a novel therapeutic drug against NASH.

Related Articles

Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis
World Journal of Gastroenterology, 10/01/09    Relevance Score: 85%

Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis
World Journal of Gastroenterology, 11/12/09    Relevance Score: 84%

A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis: A Randomized Placebo-controlled Trial
Journal of Clinical Gastroenterology, 10/22/09    Relevance Score: 83%

Drug-Induced Steatohepatitis Leading to Cirrhosis: Long-Term Toxicity of Amiodarone Use
Seminars in Liver Disease, 10/16/09    Relevance Score: 83%

Toxicant-associated steatohepatitis in vinyl chloride workers
Hepatology, 11/11/09    Relevance Score: 82%

Today in Gastroenterology...keeping you current

Adult Cyclic Vomiting Syndrome Successfully Treated with Intranasal Sumatriptan
Journal of General Internal Medicine, 11/24/09

Studies on the antidiarrhoeal activity of Aegle marmelos unripe fruit: Validating its traditional usage
BMC Complementary and Alternative Medicine, 11/24/09

The role of pouch compliance measurement in the management of pouch dysfunction
International Journal of Colorectal Disease, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address